ARXS

Arxis (ARXS) needs to formally report a backlog figure exceeding $1.8 billion for Q3 2026, demonstrating strong new order intake and reflecting the positive impact of recent acquisitions.

A significantly higher backlog provides enhanced revenue visibility and confirms sustained demand for Arxis's mission-critical components in defense and space markets, validating the long thesis and justifying a higher valuation.

Adjusted EBITDA growth of at least 35% year-over-year for Q3 2026, coupled with either a further upward revision of full-year 2026 Adjusted EBITDA guidance or strong affirmation of the high end of the current guidance range ($800 million).

Sustained high Adjusted EBITDA growth signals exceptional operational execution and effective integration of recent acquisitions, demonstrating Arxis's ability to expand profitability and leverage increased sales in a robust market, driving valuation expansion.

Total Revenue Growth of at least 28-30% year-over-year for Q3 2026, with organic growth remaining above 20%, and the company either raising its full-year 2026 revenue guidance above $1.98 billion or significantly beating current analyst consensus for Q3 revenue.

Achieving this accelerated growth rate would signal Arxis is effectively capitalizing on strong market demand and recent acquisitions, demonstrating robust market penetration and operational execution, which justifies a higher valuation multiple.

Arxis (ARXS) needs to formally report a backlog figure of at least $1.7 billion. This would confirm the 'robust backlog' previously indicated by management, which stated that approximately 90% of the projected 2026 revenue of $1.86 billion to $1.88 billion is already booked or in backlog. A figure at or above this level, coupled with strong new order intake, would signal continued robust demand in its core defense and space markets.

A formally reported backlog of at least $1.7 billion would validate Arxis' strong market position and provide clear, multi-year revenue visibility. This confirms robust contract wins, strengthens the investment thesis by demonstrating sustained demand in critical defense and space sectors, and reduces future revenue uncertainty, thereby justifying a higher valuation.

Adjusted EBITDA Growth of 30% or higher for Q2 2026, coupled with an upward revision of the full-year 2026 Adjusted EBITDA growth guidance to at least 29%.

Achieving this threshold would signal sustained strong operational execution and validate Arxis's growth strategy in the robust defense electronics and space components market. It would demonstrate the company's ability to capitalize on industry tailwinds and enhance its competitive position, driving further valuation expansion.

Total Revenue Growth needs to hit at least 25-30% year-over-year, with organic growth exceeding 20%, and the company should either raise its full-year guidance or significantly beat current analyst consensus for revenue.

Achieving this accelerated growth rate would signal Arxis is effectively capitalizing on the 'Modern Warfare '26' and 'Space Supply Chain '26' themes, demonstrating strong market share gains and operational execution. This performance would justify a higher valuation multiple, reinforcing its competitive position in critical defense and space component markets, and validating investor confidence in its long-term growth trajectory.